IDEXX Laboratories, Inc. (IDXX)财务
NASDAQ · Healthcare · Medical - Diagnostics & Research · 员工11,000人 · CEO Michael Erickson
- 股价
- $698.55 +3.94%
- 市值
- $550亿
- 企业价值
- $558亿
- 最近财报
- Q3 '26 2026-11-02提交
- 下次财报
- 2027-02-01 EPS预期 $3.33
营收(TTM)$46.6亿+11.9% 对比去年同期最近4个季度;柱状图=各季度
营业利润率(TTM)32.3%+1.0 百分点 对比去年同期营业利润 $15.1亿
净利润(TTM)$11.8亿+15.1% 对比去年同期税后,含营业外收益
自由现金流(TTM)$13亿+36.3% 对比去年同期资本支出 $1.15亿
稀释EPS(TTM)$14.73+16.8% 对比去年同期最近4个季度之和
净现金-$7.75亿+14.3% 对比去年同期现金 + 短期投资 - 债务
估值与关键数据
- 市值
- $550亿 EV $558亿
- 营收
- $46.6亿 过去12个月
- 营收增速
- +10% FY2026年一致预期
- 净利润率
- 25.4% 净利润 / 营收,TTM
- P/E
- 47.1× 预期 47.0×(FY2026)
- P/S
- 11.8× 股价 / 营收,TTM
- EV / EBITDA
- 33.4× TTM
- 自由现金流
- $13亿 过去12个月
- 净利润
- $11.8亿 过去12个月
- 营收预期
- $47.4亿 FY2026年一致预期
- 盈利
- 2027-02-01 营收预期 $11.8亿
- 股息
- – 无股息
核心要点
根据披露数据计算,每条结论都附有其依据的数字。
- 最近财报(2026-11-02):营收超预期1.9%,EPS 超预期6.2%营收$12.1亿,预期$11.9亿(+1.9%);EPS $3.96,预期$3.73(+6.2%)。
- 营收增长放缓:同比9.9%Q3 '26营收$12.1亿,此前四个季度的平均值为12.9%。
- 营业利润率32.3%(TTM),较去年同期+1.0 百分点营收增长11.9%,营业利润增长15.3%。
- 资本支出占营收的2.5%(去年为3.2%)最近4个季度投入$1.15亿(同比-14.5%)。自由现金流$13亿,相当于净利润的110.0%。
- 股东回报$10.5亿 = 自由现金流的80.6%回购$10.5亿(去年为$12.3亿),股息$0,股权激励$4960万(TTM)。
- 稀释股数一年内减少2.0%Q3 '26稀释股数7900万,一年前为8070万。
- 净债务 $7.75亿现金 + 短期投资 $1.98亿,含租赁债务 $9.73亿;一年前净债务 $9.05亿。
上一季度:Q3 '26
截至2026-09-30的季度。与去年同期及财报发布前的分析师一致预期对比。
本季度与去年同期
| Q3 '26 | 去年同期 | 变化 | |
|---|---|---|---|
| 营收 | $12.1亿 | $11.1亿 | +9.9% |
| 毛利率 | 62.9% | 61.8% | +1.1 百分点 |
| 营业利润 | $4.02亿 | $3.55亿 | +13.4% |
| 营业利润率 | 33.1% | 32.1% | +1.0 百分点 |
| 净利润 | $3.17亿 | $2.75亿 | +15.5% |
| 稀释EPS | $4.01 | $3.40 | +17.9% |
| 经营现金流 | $4.5亿 | $4.02亿 | +11.8% |
| 资本支出 | $2890万 | $3110万 | -7.0% |
| 自由现金流 | $4.21亿 | $3.71亿 | +13.4% |
| R&D | $6880万 | $6340万 | +8.5% |
| 股权激励费用 | $1620万 | -$4410万 | +136.8% |
实际 vs 一致预期
2026-11-02| 实际 | 一致预期 | 对比预期 | |
|---|---|---|---|
| 营收 | $12.1亿 | $11.9亿 | +1.9% |
| EPS(一致预期口径) | $3.96 | $3.73 | +6.2% |
来自2026-11-02发布的Q3 '26财报：营收及分析师预期口径的EPS（通常为调整后），可能与上方报表中的EPS不同。
EPS与一致预期
最近8次财报营收
收入从何而来,按业务线和地区逐季展示。
营收、营业利润与增速
季度按业务线划分的营收
堆叠,季度| 分部 | Q3 '26 | 同比 | 占比 | TTM | TTM同比 | 12个季度 |
|---|---|---|---|---|---|---|
| Product | $7.23亿 | +10.2% | 59.5% | $27.6亿 | +12.8% | |
| Service | $4.91亿 | +9.4% | 40.5% | $19亿 | +10.5% |
按地区划分的营收
占总额比例| 分部 | Q3 '26 | 同比 | 占比 | TTM | TTM同比 | 12个季度 |
|---|---|---|---|---|---|---|
| United States | $7.67亿 | +8.7% | 63.1% | $29.4亿 | +9.6% | |
| EMEA | $2.67亿 | +9.0% | 22.0% | $10.4亿 | +17.2% | |
| Asia Pacific | $1.05亿 | +15.6% | 8.6% | $3.95亿 | +14.5% | |
| CANADA | $4900万 | +18.5% | 4.0% | $1.83亿 | +11.7% | |
| Latin America | $2660万 | +15.4% | 2.2% | $1.21亿 | – |
分部利润
取自每份10-Q / 10-K分部附注的各披露分部营业利润(多数数据源缺少的利润拆分)。
Q3 '26分部
| 分部 | 营收 | 同比 | 营业利润 | 同比 | 利润率 | 去年同期利润率 | TTM营业利润 |
|---|---|---|---|---|---|---|---|
| Companion Animal Group Segment | – | – | – | – | – | – | – |
| Water Segment | – | – | – | – | – | – | – |
| Livestock And Poultry Diagnostics Segment | – | – | – | – | – | – | – |
| Other Segment | – | – | – | – | – | – | – |
| Material Reconciling Items | – | – | $56万 | -48.0% | – | – | $85.7万 |
各分部营业利润
季度各分部营业利润率
季度第四季度为推算值:10-K披露全年数据,减去10-Q的前三个季度。
利润率与成本结构
每一单位营收在各层级还剩多少,成本又花在哪里。
利润率
季度成本占营收比例
季度现金流与资本配置
创造了多少现金,用在何处,又有多少回到股东手中。
经营现金流、资本支出、自由现金流
季度现金用途与经营现金流
财年最近4个季度
现金流量表- 经营现金流
- $14.2亿
- 资本支出
- -$1.15亿
- 股票回购
- -$10.5亿
- 股息
- $0
- 收购
- -$2.28亿
- 债务净发行
- -$1.31亿
- 股权激励费用
- $4960万
- 自由现金流
- $13亿
- 股东回报 / FCF
- 80.6%
股数与EPS
季度,稀释资产负债表
各季度末的流动性、投资和债务。
现金、投资与债务
季度末估值与回报
当前估值倍数与公司自身过去五个财年对比;分析师目标价与评级。
估值倍数与回报
TTM与过去5个财年| 当前 | 5年均值 | 当前处于5年区间的位置 | |
|---|---|---|---|
| P/E(TTM) | 47.1× | 54.0× | 38.4× – 75.3× |
| EV / EBITDA | 33.4× | 38.4× | 27.3× – 54.8× |
| EV / 营收 | 12.0× | 12.5× | 8.9× – 17.7× |
| 股价 / FCF | 42.3× | 65.7× | 42.7× – 88.2× |
| 股价 / 净资产 | 29.5× | 44.7× | 21.4× – 81.3× |
| FCF收益率 | 2.4% | 1.7% | 1.1% – 2.3% |
| 投入资本回报率 | 39.9% | 36.3% | 32.5% – 41.8% |
| 净资产收益率 | 71.2% | 79.6% | 55.7% – 111.6% |
分析师
一致目标价 $716.67 (+2.6%)
区间 $700.00 – $740.00 · 评级 Buy
强烈买入0
买入13
持有9
卖出1
强烈卖出0
展望
分析师对未来财年的一致预期,以及按当前股价意味着什么。
一致预期
| 财年 | 营收 | 增速 | EPS | 增速 | 按当前股价的P/E | 分析师(EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $47.4亿 | +10.2% | $14.87 | +13.7% | 47.0× | 9 |
| FY2027 | $51.6亿 | +8.7% | $16.82 | +13.1% | 41.5× | 10 |
| FY2028 | $56.5亿 | +9.6% | $19.18 | +14.1% | 36.4× | 9 |
| FY2029 | $61.5亿 | +8.9% | $21.87 | +14.0% | 31.9× | 3 |
| FY2030 | $67.4亿 | +9.5% | $24.79 | +13.3% | 28.2× | 3 |
财务报表
利润表、资产负债表和现金流量表的每一项,含12个季度和10个财年,以金额、占营收比例或增速展示。
全部披露项目
IDEXX Laboratories, Inc.在近期10-Q / 10-K文件中标记的全部303项数据,附SEC官方标签和定义,包括附注(租赁、税务、回购、员工等)。
| 项目(SEC标签) | 最近季度 | 去年同期 | 同比 | 最近财年 | 上一财年 | 同比 |
|---|---|---|---|---|---|---|
| $2900万 | – | – | – | – | – | |
| Accounts Payable, Current | $1.54亿 | $1.22亿 | +26.0% | $1.1亿 | $1.14亿 | -3.3% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $6.16亿 | $5.67亿 | +8.6% | $5.52亿 | $4.74亿 | +16.6% |
| Accounts Receivable, Allowance for Credit Loss | $1390万 | $1170万 | +18.8% | $1130万 | $1260万 | -10.3% |
| Accounts Receivable, Allowance for Credit Loss, Current | $1130万2025-12-31 | $1260万 | -10.2% | $1130万 | $1260万 | -10.2% |
| Accrued Income Taxes, Current | $8660万 | $8920万 | -2.9% | $8870万 | $6230万 | +42.4% |
| Accrued Income Taxes, Noncurrent | $1890万 | $1480万 | +27.9% | $1450万 | $2090万 | -30.8% |
| Accrued Liabilities, Current | $5.21亿 | $4.89亿 | +6.6% | $5.3亿 | $5.02亿 | +5.6% |
| Accrued Marketing Costs, Current | $9050万 | $8640万 | +4.8% | $8760万 | $7820万 | +12.1% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $9.26亿2025-12-31 | $8.35亿 | +10.9% | $9.26亿 | $8.35亿 | +10.9% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$6050万 | -$7300万 | +17.1% | -$6880万 | -$9360万 | +26.5% |
| Additional Paid in Capital, Common Stock | $19.6亿 | $17.9亿 | +9.3% | $18.3亿 | $16.7亿 | +9.1% |
| Advertising Expense | – | – | – | $400万 | $340万 | +17.6% |
| Amortization of Intangible Assets | – | – | – | $2020万 | $1710万 | +18.1% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $1620万 | $1440万 | +12.4% | $6000万 | $6030万 | -0.5% |
| Asset Impairment Charges | $0 | $0 | – | $25万2024-12-31 | $148万 | -83.2% |
| Assets | $37.1亿 | $33.9亿 | +9.5% | $33.5亿 | $32.9亿 | +1.7% |
| Assets, Current | $15亿 | $14.8亿 | +1.6% | $14.1亿 | $14亿 | +1.0% |
| Assets, Noncurrent | $22.1亿 | $19.1亿 | +15.6% | $19.4亿 | $18.9亿 | +2.3% |
| Business Combination, Contingent Consideration, Liability | $2020万 | – | – | $180万 | $230万 | -21.7% |
| Capital Expenditures Incurred but Not yet Paid | $411万 | -$168万 | +344.2% | $1560万 | $1500万 | +3.5% |
| Capitalized Contract Cost, Net | $2090万 | $2150万 | -2.8% | $2140万 | $2200万 | -2.7% |
| Cash and Cash Equivalents, at Carrying Value | $1.98亿 | $2.08亿 | -5.1% | $1.8亿 | $2.88亿 | -37.5% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1.98亿 | $2.08亿 | -5.1% | $1.8亿 | $2.88亿 | -37.5% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $60.3万 | $4360万 | -98.6% | -$1.08亿 | -$1.66亿 | +34.7% |
| Common Stock, Other Shares, Outstanding | 2.6万 | 6万 | -56.7% | 5.9万 | 6万 | -1.7% |
| Common Stock, Other Value, Outstanding | $597万 | $623万 | -4.2% | $609万 | $589万 | +3.6% |
| Common Stock, Par or Stated Value Per Share | $0.10 | $0.10 | 0.0% | $0.10 | $0.10 | 0.0% |
| Common Stock, Shares Authorized | 1.2亿 | 1.2亿 | 0.0% | 1.2亿 | 1.2亿 | 0.0% |
| Common Stock, Shares, Issued | 1.09亿 | 1.08亿 | +0.5% | 1.08亿 | 1.08亿 | +0.5% |
| Common Stock, Shares, Outstanding | 7880万 | 8000万 | -1.5% | 7970万 | 8160万 | -2.3% |
| Common Stock, Value, Issued | $1090万 | $1080万 | +0.5% | $1080万 | $1080万 | +0.5% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $3.2亿 | $2.79亿 | +14.9% | $10.8亿 | $8.65亿 | +25.3% |
| Contract with Customer, Asset, after Allowance for Credit Loss, Current | $8570万 | $7200万 | +19.2% | $7580万 | $6080万 | +24.8% |
| Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent | $2.63亿 | $2.17亿 | +21.4% | $2.37亿 | $1.86亿 | +27.7% |
| Contract with Customer, Liability, Current | $4020万 | $3570万 | +12.6% | $3530万 | $3380万 | +4.3% |
| Contract with Customer, Liability, Noncurrent | $3270万 | $3110万 | +5.3% | $3220万 | $2690万 | +19.4% |
| Cost of Goods and Services Sold | $4.5亿 | $4.22亿 | +6.6% | $16.4亿 | $15.2亿 | +8.3% |
| Current Federal Tax Expense (Benefit) | – | – | – | $6170万 | $1.68亿 | -63.3% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $4260万 | $4100万 | +3.9% |
| Current Income Tax Expense (Benefit) | – | – | – | $1.34亿 | $2.46亿 | -45.8% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $2930万 | $3710万 | -21.2% |
| Deferred Compensation Arrangement with Individual, Fair Value of Shares Issued | $370万 | $200万 | +85.0% | – | – | – |
| Deferred Compensation Arrangement with Individual, Recorded Liability | $220万2025-12-31 | – | – | $220万 | – | – |
| Deferred Costs, Current | $8300万 | $7000万 | +18.5% | $7360万 | $6170万 | +19.3% |
| Deferred Costs, Noncurrent | $1.94亿 | $1.67亿 | +15.9% | $1.77亿 | $1.35亿 | +30.9% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | $1.17亿 | -$2460万 | +574.4% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $504万 | $516万 | -2.4% |
| Deferred Income Tax Assets, Net | $2610万 | $3150万 | -17.2% | $2790万 | $1.26亿 | -77.8% |
| Deferred Income Tax Expense (Benefit) | – | – | – | $1.31亿 | -$2420万 | +642.3% |
| Deferred Income Tax Liabilities, Net | $6120万 | $372万 | +1,542.5% | $3190万 | $1130万 | +181.7% |
| Deferred Income Taxes and Tax Credits | -$152万 | $9320万 | -101.6% | $1.31亿 | -$2420万 | +642.3% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | $928万 | -$471万 | +297.0% |
| Deferred Tax Assets, Deferred Income | $996万2025-12-31 | $574万 | +73.3% | $996万 | $574万 | +73.3% |
| Deferred Tax Assets, Gross | $1.86亿2025-12-31 | $2.78亿 | -33.2% | $1.86亿 | $2.78亿 | -33.2% |
| Deferred Tax Assets, in Process Research and Development | $202万2025-12-31 | $9290万 | -97.8% | $202万 | $9290万 | -97.8% |
| Deferred Tax Assets, Inventory | $2820万2025-12-31 | $2400万 | +17.5% | $2820万 | $2400万 | +17.5% |
| Deferred Tax Assets, Net | – | – | – | $1.14亿2024-12-31 | $1亿 | +13.9% |
| Deferred Tax Assets, Net of Valuation Allowance | $1.5亿2025-12-31 | $2.47亿 | -39.2% | $1.5亿 | $2.47亿 | -39.2% |
| Deferred Tax Assets, Operating Loss Carryforwards | $531万2025-12-31 | $665万 | -20.1% | $531万 | $665万 | -20.1% |
来源:SEC companyfacts(每份10-Q / 10-K的XBRL)。现金流量表的季度数据由10-Q标记的年初至今累计数推算。分部拆分带有维度标记,在分部章节中单独展示。
数据来源
报表、分部营收、指标和预期均根据公司文件标准化。分部利润及全部披露项目:SEC EDGAR(XBRL)。 已读取的文件: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
数据截至 2026-11-05